1. Home
  2. SMWB vs IMNM Comparison

SMWB vs IMNM Comparison

Compare SMWB & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMWB
  • IMNM
  • Stock Information
  • Founded
  • SMWB 2007
  • IMNM 2006
  • Country
  • SMWB Israel
  • IMNM United States
  • Employees
  • SMWB N/A
  • IMNM N/A
  • Industry
  • SMWB Computer Software: Programming Data Processing
  • IMNM Medicinal Chemicals and Botanical Products
  • Sector
  • SMWB Technology
  • IMNM Health Care
  • Exchange
  • SMWB Nasdaq
  • IMNM Nasdaq
  • Market Cap
  • SMWB 624.5M
  • IMNM 748.3M
  • IPO Year
  • SMWB 2021
  • IMNM 2020
  • Fundamental
  • Price
  • SMWB $7.31
  • IMNM $8.90
  • Analyst Decision
  • SMWB Strong Buy
  • IMNM Strong Buy
  • Analyst Count
  • SMWB 8
  • IMNM 5
  • Target Price
  • SMWB $15.75
  • IMNM $26.40
  • AVG Volume (30 Days)
  • SMWB 812.2K
  • IMNM 973.9K
  • Earning Date
  • SMWB 05-13-2025
  • IMNM 05-12-2025
  • Dividend Yield
  • SMWB N/A
  • IMNM N/A
  • EPS Growth
  • SMWB N/A
  • IMNM N/A
  • EPS
  • SMWB N/A
  • IMNM N/A
  • Revenue
  • SMWB $258,017,999.00
  • IMNM $10,938,000.00
  • Revenue This Year
  • SMWB $16.67
  • IMNM N/A
  • Revenue Next Year
  • SMWB $15.56
  • IMNM $542.22
  • P/E Ratio
  • SMWB N/A
  • IMNM N/A
  • Revenue Growth
  • SMWB 15.06
  • IMNM N/A
  • 52 Week Low
  • SMWB $5.71
  • IMNM $5.15
  • 52 Week High
  • SMWB $17.64
  • IMNM $16.81
  • Technical
  • Relative Strength Index (RSI)
  • SMWB 43.42
  • IMNM 58.92
  • Support Level
  • SMWB $7.22
  • IMNM $8.50
  • Resistance Level
  • SMWB $7.66
  • IMNM $9.04
  • Average True Range (ATR)
  • SMWB 0.39
  • IMNM 0.53
  • MACD
  • SMWB 0.00
  • IMNM 0.07
  • Stochastic Oscillator
  • SMWB 14.94
  • IMNM 76.16

About SMWB Similarweb Ltd.

Similarweb Ltd provides a platform for digital intelligence, delivering a trusted, comprehensive, and detailed view of the digital world that empowers customers to accelerate their growth and become more competitive in the markets. Its proprietary technology analyzes billions of digital interactions and transactions every day from millions of websites and apps and turns these digital signals into actionable insights. The company generates revenues mainly from SaaS subscriptions, which comprise subscription fees from customers utilizing cloud-based digital intelligence solutions and other subscription-based solutions. Geographically, the majority of its revenue is derived from the United States and rest from Israel, United Kingdom, Europe, Asia Pacific and other regions.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: